OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Public Statements

Office

Presidential Congressional Gubernatorial State Legislative Federal Judicial Statewide State Judicial

State

Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana National Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming

Issue

All Issues Abortion Agriculture and Food Animals and Wildlife Arts, Entertainment, and History Budget, Spending and Taxes Business and Consumers Business, Consumers, and Employees Campaign Finance Civil Liberties and Civil Rights Conservative Constitution Criminal Justice Death Penalty Defense Drugs Economy and Fiscal Education Elections Employment and Affirmative Action Energy Entitlements and the Safety Net Environment Executive Branch Family Federal, State and Local Relations Finance and Banking Fiscally Conservative Fiscally Liberal Food Processing and Sales Foreign Affairs Foreign Aid Gambling and Gaming Government Budget and Spending Government Operations Guns Health Insurance Health and Health Care High Priority Higher Education Housing and Property Ideology Immigration Impartial/Nonpartisan Indigenous Peoples Industries Infrastructure Issues Judicial Branch K-12 Education Labor Unions Legal Legislative Branch Liberal Low Priority Marijuana Marriage Military Personnel Minors and Children Monetary Policy National Security Natural Resources Oil and Gas Populations Priorities Religion Reproduction Science Science, Technology and Communication Senior Citizens Sexual Orientation and Gender Identity Social Socially Conservative Socially Liberal Stem Cell Research Taxes Technology and Communication Trade Transportation Unemployed and Low-Income Veterans Women

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.
Page 4 of 16
results per page:
75 50 25
Date Title Politician
Feb. 18, 2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal Sen. Amy Klobuchar, ...
Feb. 4, 2021 Letter to Dr. Nora D. Volkow, Director of The National Institute on Drug Abuse - Brown, Capito Lead Letter Supporting Enhanced Research and Development of Methamphetamine Treatment Options Sen. Amy Klobuchar, ...
Dec. 10, 2020 Emmer Announces $125,000 Grant for Wright County to Achieve Drug Free Communities Rep. Tom Emmer
Dec. 4, 2020 Rep. Omar Statement on House Passage of Bill to Decriminalize Marijuana and Expunge Records Nationwide Rep. Ilhan Omar
Nov. 10, 2020 Letter to the Hon. Stephen Hahn, Commissioner of FDA - U.S. Senators Tina Smith, Elizabeth Warren Question FDA On Safety Inspections for Foreign Pharmaceuticals Entering the United States Sen. Tina Smith
Nov. 10, 2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation Sen. Amy Klobuchar, ...
Sept. 15, 2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care Sen. Amy Klobuchar, ...
Aug. 17, 2020 U.S. Senator Tina Smith and Attorney General Keith Ellison Hear From Minnesotans Hit Hard by High Prescription Drug Prices During Pandemic Sen. Tina Smith
Aug. 5, 2020 U.S. Senators Tina Smith, Merkley Unveil Plan to Prevent Pharmaceutical Companies from Price Gouging COVID-19 Vaccines, Treatments Sen. Tina Smith, ...
Aug. 3, 2020 U.S Senator Tina Smith Introduces Marijuana Reform Legislation to Protect Health, Safety, Civil Rights Sen. Tina Smith
July 24, 2020 Reps. Craig and Fortenberry Introduce Bipartisan Legislation to Cut Insulin Prices Rep. Angie Craig, ...
July 20, 2020 Congresswoman Angie Craig Pushes Leadership to Include Critical Insulin Bill Rep. Angie Craig
June 6, 2020 Letter to Hon. Chad Wolf, Acting Secretary of the Department of Homeland Security - Congressmen Norcross, Chabot Lead Call for Release of Appropriated Funds for U.S. Coast Guard National Security Cutter Rep. Betty McCollum, ...
May 22, 2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies Sen. Amy Klobuchar, ...
May 19, 2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package Sen. Tina Smith, ...
April 16, 2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic Sen. Amy Klobuchar, ...
March 11, 2020 Cárdenas, Hudson, Craig, Fitzpatrick Introduce the Increasing Access to Biosimilars Act Rep. Angie Craig, ...
Feb. 19, 2020 NBC Las Vegas Democratic Debate Sen. Amy Klobuchar, ...
Feb. 6, 2020 The Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act (S. Rep. Betty McCollum
Jan. 23, 2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products Rep. Betty McCollum, ...
Dec. 19, 2019 PBS December Democratic Debate Sen. Amy Klobuchar, ...
Dec. 17, 2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO Sen. Amy Klobuchar, ...
Oct. 29, 2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes Sen. Amy Klobuchar, ...
Sept. 19, 2019 Letter to the Hon. Ned Sharpless, Acting Commissioner U.S. Food and Drug Administration - Pingree Leads Bipartisan Letter to FDA Urging Legal Pathway for CBD Rep. Betty McCollum, ...
Sept. 11, 2019 Stauber Announces High Intensity Drug Trafficking Area Designation for St. Louis County Rep. Pete Stauber
Date Title Politician
Feb. 18, 2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal Sen.Amy Klobuchar, ...
Feb. 4, 2021 Letter to Dr. Nora D. Volkow, Director of The National Institute on Drug Abuse - Brown, Capito Lead Letter Supporting Enhanced Research and Development of Methamphetamine Treatment Options Sen.Amy Klobuchar, ...
Dec. 10, 2020 Emmer Announces $125,000 Grant for Wright County to Achieve Drug Free Communities Rep.Tom Emmer
Dec. 4, 2020 Rep. Omar Statement on House Passage of Bill to Decriminalize Marijuana and Expunge Records Nationwide Rep.Ilhan Omar
Nov. 10, 2020 Letter to the Hon. Stephen Hahn, Commissioner of FDA - U.S. Senators Tina Smith, Elizabeth Warren Question FDA On Safety Inspections for Foreign Pharmaceuticals Entering the United States Sen.Tina Smith
Nov. 10, 2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation Sen.Amy Klobuchar, ...
Sept. 15, 2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care Sen.Amy Klobuchar, ...
Aug. 17, 2020 U.S. Senator Tina Smith and Attorney General Keith Ellison Hear From Minnesotans Hit Hard by High Prescription Drug Prices During Pandemic Sen.Tina Smith
Aug. 5, 2020 U.S. Senators Tina Smith, Merkley Unveil Plan to Prevent Pharmaceutical Companies from Price Gouging COVID-19 Vaccines, Treatments Sen.Tina Smith, ...
Aug. 3, 2020 U.S Senator Tina Smith Introduces Marijuana Reform Legislation to Protect Health, Safety, Civil Rights Sen.Tina Smith
July 24, 2020 Reps. Craig and Fortenberry Introduce Bipartisan Legislation to Cut Insulin Prices Rep.Angie Craig, ...
July 20, 2020 Congresswoman Angie Craig Pushes Leadership to Include Critical Insulin Bill Rep.Angie Craig
June 6, 2020 Letter to Hon. Chad Wolf, Acting Secretary of the Department of Homeland Security - Congressmen Norcross, Chabot Lead Call for Release of Appropriated Funds for U.S. Coast Guard National Security Cutter Rep.Betty McCollum, ...
May 22, 2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies Sen.Amy Klobuchar, ...
May 19, 2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package Sen.Tina Smith, ...
April 16, 2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic Sen.Amy Klobuchar, ...
March 11, 2020 Cárdenas, Hudson, Craig, Fitzpatrick Introduce the Increasing Access to Biosimilars Act Rep.Angie Craig, ...
Feb. 19, 2020 NBC Las Vegas Democratic Debate Sen.Amy Klobuchar, ...
Feb. 6, 2020 The Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act (S. Rep.Betty McCollum
Jan. 23, 2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products Rep.Betty McCollum, ...
Dec. 19, 2019 PBS December Democratic Debate Sen.Amy Klobuchar, ...
Dec. 17, 2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO Sen.Amy Klobuchar, ...
Oct. 29, 2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes Sen.Amy Klobuchar, ...
Sept. 19, 2019 Letter to the Hon. Ned Sharpless, Acting Commissioner U.S. Food and Drug Administration - Pingree Leads Bipartisan Letter to FDA Urging Legal Pathway for CBD Rep.Betty McCollum, ...
Sept. 11, 2019 Stauber Announces High Intensity Drug Trafficking Area Designation for St. Louis County Rep.Pete Stauber
Page 4 of 16
arrow_upward